Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Shoulder Elbow Surg ; 19(7): 1085-90, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20510631

ABSTRACT

BACKGROUND: Reported healing rates of a subscapularis tenotomy have been extremely variable in the literature. The purpose of this study was to document the subscapularis healing rate after subscapularis tenotomy using ultrasound, and to correlate healing with physical examination findings and shoulder internal rotation strength. METHODS: Fifteen patients who underwent total shoulder arthroplasty due to unilateral osteoarthritis were evaluated after a minimum of 6 months follow-up with ultrasound, physical examination, and internal rotation strength testing. At surgery, a subscapularis tenotomy utilized to approach the shoulder. Postoperatively, no formal physical therapy program was utilized. RESULTS: Seven of the 15 shoulders had a complete tear of the repaired subscapularis tendon based on ultrasound examination. The lift-off and abdominal compression tests correlated poorly with the ultrasonographic condition of the subscapularis. The bear hug test using dynamometry did correlate with tendon integrity. Patients with a subscapularis tear after arthroplasty experienced significant weakness in isometric (P = .01) and isokinetic (P < .01) internal rotation strength testing, as well as significantly worse DASH scores (P = .04). No patient demonstrated anterior subluxation on examination or by radiograph. CONCLUSION: Subscapularis tear after total shoulder arthroplasty is a common finding, which cannot be diagnosed reliably by physical examination or radiographs. In this population, subscapularis integrity did not correlate with pain or subjective patient outcome. Failure to heal the subscapularis tenotomy is probably more common than has been previously reported based on only physical examination testing.


Subject(s)
Arthroplasty, Replacement , Shoulder Joint/surgery , Tendons/surgery , Tenotomy , Wound Healing , Arthroplasty, Replacement/methods , Humans , Magnetic Resonance Imaging , Osteoarthritis/surgery , Pain Measurement , Physical Examination , Recovery of Function , Rotation , Sensitivity and Specificity , Shoulder Joint/diagnostic imaging , Shoulder Joint/physiopathology , Tendons/diagnostic imaging , Tendons/physiopathology , Treatment Outcome , Ultrasonography
2.
Am J Sports Med ; 37(11): 2201-4, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19684299

ABSTRACT

BACKGROUND: Golf provides an opportunity for relatively low-impact exercise for nearly all age groups and is considered a recommended activity for patients after total knee arthroplasty. HYPOTHESIS: We hypothesized that total knee arthroplasty would afford patients increased ability to participate in and enjoy golf, allowing a large percentage of these patients to walk the golf course. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Surveys were sent to 151 golfers who had undergone primary total knee arthroplasty from 1995 to 2000. The detailed survey included 33 questions specific to the patients' golf performance, enjoyment of golf, frequency of participation, timing of return to play, presence of pain, use of a cart, and related golf-specific issues. RESULTS: We received and evaluated 93 responses (62%). Fifty-seven percent reported they had returned to golf within 6 months after total knee arthroplasty. Eighty-one percent of respondents reported golfing as frequently, or more frequently, than before knee replacement. Notably, golfers reported less pain while golfing after total knee arthroplasty than before (13% vs 83%; P < .0001), and 94% of respondents reported currently enjoying golf as much as or more than before surgery. Twenty-eight percent of respondents stated that they walked the course, rather than using a motorized golf cart, before surgery, while only 14% walked the course after surgery (P = .02). CONCLUSION: In this population of golfers, total knee arthroplasty reliably relieved pain that had been previously experienced while golfing, and increased or maintained this group's enjoyment of playing golf. However, 86% of these patients reported using a cart while golfing. Further patient education is needed regarding the potential health benefits of walking during golf after total knee arthroplasty.


Subject(s)
Arthroplasty, Replacement, Knee , Golf/physiology , Walking/physiology , Adult , Aged , Exercise , Female , Humans , Male , Middle Aged , Recovery of Function
3.
Arthroscopy ; 24(3): 292-8, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18308180

ABSTRACT

PURPOSE: Studies have suggested good long-term success rates with bone-patellar tendon-bone (BPTB) autograft and BPTB allograft in anterior cruciate ligament (ACL) reconstruction, but the numbers reported in available prospective studies may be underpowered to elucidate significant differences between the two groups. Here, we present a meta-analysis to compare the results of BPTB autograft and BPTB allograft in primary ACL reconstruction. METHODS: A systematic review of prospective trials using BPTB autograft and BPTB allograft tissue for ACL reconstruction with a minimum 2-year follow-up was performed. Summary odds ratios (ORs), confidence intervals, and P values were calculated. RESULTS: Of 548 studies, 6 fulfilled our inclusion criteria, with 256 patients in the autograft and 278 patients in the allograft group. Allograft patients were more likely to rupture their graft than autograft patients (OR, 5.03; P = .01) and more likely to have a hop test less than 90% of the nonoperative side (OR, 5.66; P < .01). When irradiated and chemically processed grafts were excluded from analysis, no significant differences were found between allograft and autograft patients with respect to graft rupture, rate of reoperation, normal/near normal IKDC scores, Lachman exam, pivot shift exam, patellar crepitus, hop test, or return to sport. CONCLUSIONS: In this meta-analysis, ACL reconstruction with BPTB autograft was favored over BPTB allograft for graft rupture and hop test parameters. However, when irradiated and chemically processed grafts were excluded, results were not significantly different between the two graft types. LEVEL OF EVIDENCE: Level III, systematic review of prospective nonrandomized cohort studies.


Subject(s)
Anterior Cruciate Ligament/surgery , Arthroscopy , Patellar Ligament/transplantation , Adult , Female , Humans , Male , Middle Aged , Transplantation, Autologous , Transplantation, Homologous
4.
J Arthroplasty ; 22(6 Suppl 2): 140-4, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17823033

ABSTRACT

Large-diameter femoral heads, which may reduce dislocation, are used without extensive in vivo research. Two studies were done to determine relative dislocation rates. Study 1 compared dislocation rates in primary total hip arthroplasties (THAs) using 28- or 38-mm heads. Study 2 evaluated dislocation rates in large-diameter (38-56 mm) metal-on-metal heads. In study 1, 136 patients with 38-mm heads via posterior approach and 160 patients with 28-mm heads via Hardinge approach had an average of 52 months of follow-up (range, 32-106 months). In study 2, 469 patients had THA with large-diameter metal-on-metal heads, with an average of 36 months of follow-up (range, 24-46 months). Harris hip scores evaluated the clinical outcomes. Study 1 had no dislocations in the 38-mm group and had 4 dislocations (2.5%) in the 28-mm group (P = .12). Study 2 had 2 dislocations (0.4%). Dislocation rates in primary THA with 38-mm bearings via posterior approach are the same as 28-mm bearings via Hardinge approach. Metal-on-metal THA with 38 to 56 mm heads is also associated with low dislocation rates (0.4%) at short-term follow-up.


Subject(s)
Arthroplasty, Replacement, Hip/instrumentation , Hip Dislocation/prevention & control , Hip Prosthesis , Adolescent , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Complications , Prospective Studies , Prosthesis Design
5.
Hand Clin ; 23(2): 185-93, vi, 2007 May.
Article in English | MEDLINE | ID: mdl-17548010

ABSTRACT

Radial head fractures are the most common adult elbow fracture. Our ability to treat these fractures has improved with increased understanding of elbow biomechanics. Based on fracture type, possible treatment includes nonoperative management, open reduction and internal fixation, radial head resection, and replacement arthroplasty. Management and operative technique are discussed.


Subject(s)
Radius Fractures/surgery , Arthroplasty, Replacement , Elbow Joint/surgery , Fracture Fixation, Internal , Humans , Radius Fractures/classification , Elbow Injuries
6.
J Gastrointest Surg ; 10(8): 1120-30, 2006.
Article in English | MEDLINE | ID: mdl-16966031

ABSTRACT

Peroxisome proliferator-activated receptors (PPARs) are ligand-inducible transcription factors that regulate cellular energy and lipid metabolism. PPAR-gamma agonists also have potent anti-inflammatory properties through down-regulation of early inflammatory response genes. The role of PPAR-gamma in acute pancreatitis has not been adequately examined. In this study, we determined the effect of PPAR-gamma agonists on the severity of pancreatitis and sought to correlate PPAR-gamma expression in pancreatic acinar cells and the severity of acute pancreatitis in vivo. Acute pancreatitis was induced in mice by hyperstimulation with the cholecystokinin analog, cerulein. PPAR-gamma agonists were administered by intraperitoneal injection 15-30 minutes before induction of pancreatitis (pretreatment) or at various times after induction of pancreatitis (treatment). Pancreata and serum were harvested over the course of 24 hours. Serum amylase activity and glucose levels were measured. Pancreata were used for histological evaluation as well as protein and mRNA analysis. Pretreatment of mice with the PPAR-gamma agonists 15-deoxy-Delta12, 14-prostaglandin J(2), or troglitazone significantly reduced the severity of pancreatitis in a dose-dependent manner. This reduction was indicated by reduced serum amylase activity and histological damage (leukocyte infiltration, vacuolization, and necrosis). Although cerulein decreased PPAR-gamma expression in the pancreas, pretreatment with agonists maintained PPAR-gamma expression early in acute pancreatitis. The expression of PPAR-gamma inversely correlated with pancreatitis severity and expression of the proinflammatory cytokines, interleukin-6, and tumor necrosis factor-alpha. Treatment with troglitazone after the induction of pancreatitis reduced serum amylase activity. The results suggest that PPAR-gamma plays a direct role in the inflammatory cascade during the early events of acute pancreatitis. Our data are the first to demonstrate that PPAR-gamma agonists represent a promising therapeutic strategy for acute pancreatitis.


Subject(s)
Gene Expression , Pancreatitis, Acute Necrotizing/drug therapy , Prostaglandin D2/analogs & derivatives , RNA, Messenger/genetics , Animals , Blotting, Western , Ceruletide/toxicity , Chromans/therapeutic use , Disease Models, Animal , Follow-Up Studies , Male , Mice , Mice, Inbred C3H , PPAR gamma/agonists , PPAR gamma/blood , PPAR gamma/genetics , Pancreatitis, Acute Necrotizing/blood , Pancreatitis, Acute Necrotizing/chemically induced , Prostaglandin D2/therapeutic use , Reverse Transcriptase Polymerase Chain Reaction , Severity of Illness Index , Thiazolidinediones/therapeutic use , Treatment Outcome , Troglitazone , Vasodilator Agents/therapeutic use
7.
BMC Gastroenterol ; 5: 18, 2005 Jun 06.
Article in English | MEDLINE | ID: mdl-15938756

ABSTRACT

BACKGROUND: Gastric ileus is an unsolved clinical problem and current treatment is limited to supportive measures. Models of ileus using anesthetized animals, muscle strips or isolated smooth muscle cells do not adequately reproduce the clinical situation. Thus, previous studies using these techniques have not led to a clear understanding of the pathophysiology of ileus. The feasibility of using food intake and fecal output as simple, clinically relevant endpoints for monitoring ileus in a conscious mouse model was evaluated by assessing the severity and time course of various insults known to cause ileus. METHODS: Delayed food intake and fecal output associated with ileus was monitored after intraperitoneal injection of endotoxin, laparotomy with bowel manipulation, thermal injury or cerulein induced acute pancreatitis. The correlation of decreased food intake after endotoxin injection with gastric ileus was validated by measuring gastric emptying. The effect of endotoxin on general activity level and feeding behavior was also determined. Small bowel transit was measured using a phenol red marker. RESULTS: Each insult resulted in a transient and comparable decrease in food intake and fecal output consistent with the clinical picture of ileus. The endpoints were highly sensitive to small changes in low doses of endotoxin, the extent of bowel manipulation, and cerulein dose. The delay in food intake directly correlated with delayed gastric emptying. Changes in general activity and feeding behavior were insufficient to explain decreased food intake. Intestinal transit remained unchanged at the times measured. CONCLUSION: Food intake and fecal output are sensitive markers of gastric dysfunction in four experimental models of ileus. In the mouse, delayed gastric emptying appears to be the major cause of the anorexic effect associated with ileus. Gastric dysfunction is more important than small bowel dysfunction in this model. Recovery of stomach function appears to be simultaneous to colonic recovery.


Subject(s)
Consciousness , Disease Models, Animal , Gastric Outlet Obstruction/physiopathology , Gastric Outlet Obstruction/psychology , Animals , Blood Pressure/drug effects , Defecation/drug effects , Dose-Response Relationship, Drug , Eating/drug effects , Endotoxins/administration & dosage , Gastric Emptying/drug effects , Gastric Outlet Obstruction/chemically induced , Gastrointestinal Transit/drug effects , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/pharmacology , Male , Mice , Mice, Inbred C3H , Motor Activity/drug effects , Time Factors
8.
Am J Nephrol ; 25(1): 45-9, 2005.
Article in English | MEDLINE | ID: mdl-15724082

ABSTRACT

BACKGROUND: Uric acid is a nontraditional risk factor implicated in the development of coronary artery disease (CAD). This study prospectively evaluated the predictive value of serum uric acid (SUA) levels for mortality after angiographic diagnosis of CAD. METHODS: Blood samples were collected from 1,595 consecutive, consenting patients with significant, angiographically defined CAD (stenosis 70%). Baseline and procedural variables were recorded and levels of SUA were measured. Patients were followed to death or to the time of contact (mean 2.6 years, range 1.8-5.0 years). RESULTS: Patients averaged 65 +/- 11 years of age, 78% were male and 170 subjects died during the follow-up period. In univariate analysis of prospectively defined quintiles, SUA predicted all-cause mortality (fifth quintile vs. first four quintiles: hazard ratio 1.9, p < 0.001). In multivariable Cox regression controlling for 20 covariables, independent predictive value for mortality was retained by SUA (hazard ratio 1.5, confidence interval 1.02-2.1, p = 0.04). In subgroup analysis based on diuretic use status, SUA independently predicted mortality among patients not using diuretics, while SUA was not a significant predictor of mortality among those who used diuretics. CONCLUSIONS: In patients with significant, angiographically defined CAD, SUA predicted mortality independent of traditional risk factors. This suggests that elevated SUA may be a risk factor for mortality in patients with significant cardiovascular disease and may be a stronger secondary than primary risk factor in CAD.


Subject(s)
Coronary Disease/mortality , Uric Acid/blood , Aged , Cohort Studies , Coronary Angiography , Coronary Disease/blood , Coronary Disease/diagnostic imaging , Female , Humans , Longitudinal Studies , Male , Predictive Value of Tests , Proportional Hazards Models , Prospective Studies , Risk Factors , Time Factors
9.
J Surg Res ; 116(2): 197-201, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15013356

ABSTRACT

BACKGROUND: We hypothesized that the changing environment of academic surgery has resulted in a decrease in surgical research funding and basic surgical research productivity of academic departments of surgery. MATERIALS AND METHODS: Trends in National Institutes of Health (NIH) grants to Departments of Medicine and Surgery were analyzed from 1992 to 1999. To assess trends in research productivity, selected basic science journals were screened from 1988 to 1999 for the number of basic research publications where authors cited affiliation with a Department of Medicine or Surgery. RESULTS: NIH funding to Schools of Medicine increased 5.9% per year from 1992 to 1999. Funding to Departments of Medicine increased 21.1% per year, whereas funding to Surgery increased 3.1% per year. As a percentage of total funding to medical schools, NIH funding to Departments of Surgery declined slightly and funding to Departments of Medicine increased 1% per year. The number of grants awarded to Schools of Medicine and Departments of Surgery and Medicine remained constant from 1992 to 1999. The number of publications in basic science journals trended up for both Departments of Surgery and Departments of Medicine. As a percentage of departmental totals, Departments of Surgery publications increased by 9.5% yearly and Departments of Medicine increased 1.5% per year. CONCLUSION: Support for basic surgical research has been static. Despite static grant support, basic research productivity has increased for Departments of Surgery. Basic surgical research remains an integral part of academic surgery department activity.


Subject(s)
Academic Medical Centers , Financing, Government/trends , National Institutes of Health (U.S.) , Research Support as Topic/trends , Research/trends , Surgery Department, Hospital , Humans , Periodicals as Topic , Publishing , United States
10.
Am Heart J ; 145(5): 875-81, 2003 May.
Article in English | MEDLINE | ID: mdl-12766747

ABSTRACT

BACKGROUND: Restenosis after percutaneous transluminal coronary intervention (PCI) remains a serious complication in the treatment of coronary artery disease. Although beta-adrenergic receptor blockers (BBs) effectively reduce many cardiac events, no large prospective studies have examined the association of BBs with restenosis. METHODS: We prospectively evaluated the association of BBs (prescribed at hospital discharge) with clinical restenosis in 4840 patients who underwent stent placement (60%), balloon angioplasty (32%), or rotational atherectomy (8%). Clinical restenosis was defined as repeat target lesion revascularization or coronary artery bypass grafting within 6 months of PCI. Other end points included 9-month clinical restenosis, repeat target lesion PCI (only), long-term (5-year) target lesion repeat-PCI, and major adverse cardiac events (MACE). Multivariable regression adjusted the effect of BBs on clinical restenosis for 15 covariables. RESULTS: The average patient age was 63 years, 75% were men, and 37% received a BB prescription. The incidence of clinical restenosis was 12% overall and was lower among those prescribed a BB (10.0% for BB, 13.5% for none, adjusted odds ratio [OR] 0.76, P =.004). Other predictors of decreased restenosis included stent use, age, and smoking; predictors of increased restenosis included diabetes, atherectomy, and number of treated vessels. BBs also reduced 9-month clinical restenosis (10.3% vs 13.5%, OR 0.75, P =.004), MACE (16.5% vs 20.9%, OR 0.75, P <.001), 6-month target lesion restenosis (7.8% vs 10.2%, OR 0.75, P =.006), and 5-year target lesion restenosis (12.0% vs 14.0%, OR 0.83, P =.046). CONCLUSIONS: beta-Adrenergic receptor blockers prescribed after PCI reduced the risk of clinical restenosis, target lesion restenosis, and MACE in this cohort of 4840 patients. The mechanism by which beta-blockers conferred a protective effect against restenosis remains to be determined.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Coronary Restenosis/prevention & control , Angioplasty, Balloon, Coronary , Atherectomy, Coronary , Coronary Stenosis/therapy , Female , Humans , Male , Middle Aged , Odds Ratio , Prospective Studies , Regression Analysis , Stents
SELECTION OF CITATIONS
SEARCH DETAIL
...